LINC02035

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, LINC02035 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC02035 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher LINC02035 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02035 expression acts as an unfavorable survival marker.

ESCA are the cancer types where LINC02035 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
ESCAOSMedianII,III,IV0.1300.703<.00124view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

LINC02035–ESCA (OS)

Kaplan–Meier survival curve for LINC02035 mutant vs wild-type samples in ESCA.

Open the ESCA breakdown →

Exploration